[BRNS] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -47.48%
YoY- 280.86%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 14,969 0 6,165 19 3,251 46.44%
PBT -8,132 -14,713 7,547 -4,577 200 -
Tax -18 -603 -674 -7 1,011 -
NP -8,114 -14,072 8,242 -4,557 158 -
Tax Rate - - 8.93% - -505.50% -
Total Cost 23,083 14,072 -2,077 4,576 3,093 65.22%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin -54.21 0.00 133.69 -23,984.21 4.86 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.21 -0.37 0.22 -0.13 3.32 -
EPS Diluted -0.21 -0.37 0.22 -0.13 3.32 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.